Through our venture philanthropy model, we provide early stage funding to companies to develop breakthrough drugs for adults and children with cystic fibrosis.
Site Search
Showing 1 - 10 of 109 results
Learn about our focus for 2020-2024 as we advance our path to a cure, meet emerging challenges in care, and explore new ways to partner with and support the CF community.
10 min read
Engaging with biotechnology and pharmaceutical companies is essential to reaching our goal of a cure for all people with cystic fibrosis. These principles and standards for Industry interactions safeguard our independence, objectivity, and ability to make decisions that are in the best interest of people with CF.
13 min read
Press Release
|
|
6 min read
Press Release
|
|
3 min read
CF Foundation's $1 Million Investment Helped Drug Known as Cayston® Become a Reality
Press Release
|
|
4 min read
Press Release
|
|
3 min read
Kids from 20 States Make Case for Drug Funding and Access to Care for Fatal Disease
Press Release
|
|
2 min read
New Effort Will Search for Potential Therapies Targeting the Most Common Mutation of Cystic Fibrosis
Press Release
|
|
4 min read
Kalydeco Marks the Latest Success of the Cystic Fibrosis Foundation’s Venture Philanthropy Model
Press Release
|
|
5 min read